Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 15.4.2026ratiopharm GmbH (RAT)6548BEporatio 30000 IU/1,0 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 6x1,0 ml/30000 IU ( striek.skl.napl. s bezpeč.ihlou))13.4.2026O
 15.4.2026ratiopharm GmbH (RAT)37698Moxonidin-ratiopharm 0,2 mg (tbl flm 100x0,2 mg (blis.PVC/PVDC/Al))1.6.2026R
 15.4.2026Teva B.V. (TEV-NL-4)28620Hylak forte (gto por 1x100 ml (liek.skl.hnedá))1.7.2026R
 15.4.2026Laboratoires THEA (LHH-1)4320AMONOPOST 50 mikrogramov/ml (int osd 90(18x5)x0,2 ml (obal LDPE jednodáv.))15.4.2026U
 15.4.2026Instituto Grifols, S.A. (GFO)57419IGANTIBE 200 IU/ml (sol inj 1x3 ml/600 IU (amp.skl.))15.4.2026Z
 15.4.2026Instituto Grifols, S.A. (GFO)57420IGANTIBE 200 IU/ml (sol inj 1x5 ml/1000 IU (amp.skl.))15.4.2026Z
 15.4.2026Pfizer Europe MA EEIG (PFI-BE-3)6770DTUKYSA 150 mg filmom obalené tablety (tbl flm 84x150 mg (blis.OPA/PVC/Al))15.4.2026U
 15.4.2026Cooper Consumer Health B.V. (CO2)62565DUPHALAC (sir 1x500 ml (fľ.HDPE))15.4.2026O
 15.4.2026McNeil Healthcare (Ireland) Limited (MCP-3)6797COLYNTH PLUS 1 mg/50 mg/ml nosový roztokový sprej (aer nao 1x10 ml (fľ.HDPE biela))29.5.2026R
 15.4.2026G.L. Pharma GmbH (GLH-2)9101BTrigelan 150 mg/37,5 mg/200 mg filmom obalené tablety (tbl flm 100x150 mg/37,5 mg/200 mg (fľ.HDPE))14.4.2026O
 14.4.2026Bayer AG (BAY)6622DXarelto 1 mg/ml granulát na perorálnu suspenziu (gru por 1x2,625 g/51,7 mg (fľ.skl.hnedá))20.4.2026R
 14.4.2026Biosimilar Collaborations Ireland Limited (BTT)7459DAbevmy 25 mg/ml koncentrát na infúzny roztok (con inf 1x4 ml/100 mg (liek.inj.skl.))14.4.2026R
 14.4.2026Biosimilar Collaborations Ireland Limited (BTT)7461DAbevmy 25 mg/ml koncentrát na infúzny roztok (con inf 1x16 ml/400 mg (liek.inj.skl.))14.4.2026R
 14.4.2026Zentiva, k.s. (ZNT-1)05041Ozzion 40 mg gastrorezistentné tablety (tbl ent 28x40 mg (blis.nylon/Al/PVC/Al))30.6.2026Z
 14.4.2026Zentiva, k.s. (ZNT-1)0567BOzzion 40 mg gastrorezistentné tablety (tbl ent 98x40 mg (blis.nylon/Al/PVC/Al))30.6.2026Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)